Dr Reddy's Laboratories (RDY) stock plummeted 5.10% during intraday trading on Tuesday, following the release of its quarterly financial results.
The pharmaceutical company reported quarterly earnings of $0.03 per share, which missed the analyst consensus estimate of $0.09 by 66.67 percent and represented an 86.36 percent decrease from the same period last year. Furthermore, quarterly sales of $821.821 million missed the analyst estimate of $866.120 million by 5.11 percent and marked a 17.49 percent decrease year-over-year.